{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:54:59Z","timestamp":1772772899670,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.bbrc.2005.07.100","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T16:39:19Z","timestamp":1122655159000},"page":"432-436","source":"Crossref","is-referenced-by-count":14,"title":["Engineered \u03b1-synuclein prevents wild type and familial Parkin variant fibril formation"],"prefix":"10.1016","volume":"335","author":[{"given":"Koji","family":"Sode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Usuzaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2005.07.100_bib1","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2005.07.100_bib2","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer\u2019s disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2005.07.100_bib3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2005.07.100_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/bi020429y","article-title":"The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation","volume":"42","author":"Kessler","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2005.07.100_bib5","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of alpha-synuclein carboxy-terminus on fibril formation in vitro","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2005.07.100_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-8993(98)00514-9","article-title":"Human recombinant NACP\/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease","volume":"799","author":"Hashimoto","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2005.07.100_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-5793(02)02883-1","article-title":"Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle","volume":"522","author":"Uversky","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2005.07.100_bib8","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1021\/bi034028+","article-title":"A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein","volume":"42","author":"Du","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2005.07.100_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01418-5","article-title":"Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2005.07.100_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrc.2005.07.100_bib11","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","article-title":"alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson\u2019s disease","volume":"274","author":"Wood","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2005.07.100_bib12","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in alpha-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X05015871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X05015871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T06:55:25Z","timestamp":1548312925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X05015871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0006291X05015871"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2005.07.100","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}